DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
It's - 2 Paul Polman - 1 Naomi Wheeless - 1 Eventbrite - 1 Donald Trump - 1 Larry Fink - 1 George Floyd's - 1 ESG - 1
Top related locs:
Plenty America ESG New Charlottesville GLP U.S
Top related orgs:
Unilever - 2 Unilever isn't - 2 Unilever wasn't - 1 Companies - 1 Business - 1 Sporting Goods - 1 Conference Board's ESG - 1 Morningstar - 1

Search resuls for: "Unilever isn't"


2 mentions found


☆ Corporate America Is Going Un-Woke: Reversing DEI, Sustainability Plan
  + stars: | 2024-05-09 | by ( Emily Stewart | ) www.businessinsider.com   time to read: +10 min
Plenty of companies are reining in their rhetoric and in some cases action on issues such as sustainability and diversity. Over the past decade, many corporations have at least professed to take a more active role in social issues, under pressure from their customers and, more importantly, employees. After last year's Bud Light debacle, which was a real blow to its business, executives fear they'll be the next target of some anti-woke outcry. For the fourth quarter of 2020, 131 companies mentioned ESG, and 34 mentioned DEI or diversity and inclusion. This may be a great un-wokening, but maybe corporate America was actually never that committed to the idea in the first place.
Persons: Paul Polman, It's, Naomi Wheeless, Eventbrite, Donald Trump, Larry Fink, George Floyd's, ESG, Andrew Jones, there's, Bud Light, influencer Dylan Mulvaney, haven't, Philip Mirvis, Bud, they'll, they'd, Jones, it's, Fink, FactSet, — we're, wasn't, Alison Taylor, University's, we've, Roe, Wade, Taylor, isn't, Dylan Mulvaney, Bud Light's, Kenneth Pucker, Emily Stewart Organizations: Unilever, Unilever wasn't, Unilever isn't, Companies, Business, Sporting Goods, Conference Board's ESG, Morningstar, Babson, AIG, Amazon, ExxonMobil, University's Stern School of Business, Anheuser, Busch, Fletcher School, Tufts University Locations: Plenty, America, ESG, New, Charlottesville
☆ GLP-1 weight loss drugs are creating opportunities for these 2 stocks, investment advisor says
  + stars: | 2023-10-18 | by ( Weizhen Tan | ) www.cnbc.com   time to read: +3 min
Developments surrounding the drugs, also popularly used for weight loss, have been disrupting anything from owners of dialysis centers to bariatric surgery providers and the food industry. But one investment advisor, Brian Krawez, president of Scharf Investments, says there are opportunities. "Many investors are concerned about the impacts of the GLP-1 drugs on a host of companies ranging from restaurants to consumer staples. Those mechanisms are the ones that help patients taking the drugs to lose weight and regulate their diabetes. They got roughly 35% market share, but a lot of people don't know the company," he said, adding that specialty pharmaceuticals — including the GLP-1 drugs —account for roughly 35% of the company's earnings.
Persons: Brian Krawez, Scharf, Mounjaro, Krawez, CNBC's, McKesson, It's, —, Christina Cheddar Berk, Julie Coleman Organizations: Scharf Investments, CNBC, Novo Nordisk, Walmart, Unilever, Unilever isn't Locations: GLP, U.S
0 next >>
Total: 2